Intelligent Bio Solutions’ FDA Clearance Process Remains on Track for 2025 U.S. Launch
On December 18, 2024, the Company announced the submission of its 510 (k) premarket notification to the U.S. Food and Drug Administration (FDA) for review and clearance of its Intelligent ...